Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

2.

Managed approaches to multiple sclerosis in special populations.

Sperandeo K, Nogrady L, Moreo K, Prostko CR.

J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl C):S1-19; quiz S20-1. Review.

PMID:
22107156
3.

Consensus statements from a panel of U.S. managed care pharmacists and physicians for management of multiple sclerosis agents.

Phillips JT.

J Manag Care Pharm. 2012 Apr;18(3):277; author reply 277-8. No abstract available.

4.

Consensus statements from a panel of U.S. managed care pharmacists and physicians for management of multiple sclerosis agents.

Kern R, Grinspan A, Kim E.

J Manag Care Pharm. 2012 Apr;18(3):276-7; author reply 277-8. No abstract available.

5.
6.

Assessment of the Level of Satisfaction and Unmet Data Needs for Specialty Drug Formulary Decisions in the United States.

Choi Y, Navarro RP.

J Manag Care Spec Pharm. 2016 Apr;22(4):368-75. doi: 10.18553/jmcp.2016.22.4.368.

7.

Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach.

Fernandes O, Gorman SK, Slavik RS, Semchuk WM, Shalansky S, Bussières JF, Doucette D, Bannerman H, Lo J, Shukla S, Chan WW, Benninger N, MacKinnon NJ, Bell CM, Slobodan J, Lyder C, Zed PJ, Toombs K.

Ann Pharmacother. 2015 Jun;49(6):656-69. doi: 10.1177/1060028015577445. Epub 2015 Mar 16.

PMID:
25780250
8.

Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies.

Owens GM, Olvey EL, Skrepnek GH, Pill MW.

J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S41-53. Review.

9.

Managed care aspects of managing multiple sclerosis.

Owens GM.

Am J Manag Care. 2013 Nov;19(16 Suppl):s307-12. Review.

10.

Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice.

Tonna A, McCaig D, Diack L, West B, Stewart D.

Int J Clin Pharm. 2014 Oct;36(5):1069-76. doi: 10.1007/s11096-014-9996-8. Epub 2014 Aug 10.

PMID:
25108412
11.

AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.

[No authors listed]

J Manag Care Spec Pharm. 2016 Jul;22(7):826-31. doi: 10.18553/jmcp.2016.22.7.826.

12.
13.

Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.

Bandari DS, Sternaman D, Chan T, Prostko CR, Sapir T.

J Manag Care Pharm. 2012 Nov-Dec;18(9):1-17.

14.

Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience.

Watkins JB, Minshall ME, Sullivan SD.

J Manag Care Pharm. 2006 Nov-Dec;12(9):726-35.

15.

Current and future directions in MS management: key considerations for managed care pharmacists.

Lipsy RJ, Schapiro RT, Prostko CR.

J Manag Care Pharm. 2009 Nov-Dec;15(9 Suppl A):S2-15; quiz S16-7. Review.

PMID:
19877743
16.

Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.

Radomski TR, Good CB, Thorpe CT, Zhao X, Marcum ZA, Glassman PA, Lowe J, Mor MK, Fine MJ, Gellad WF.

J Manag Care Spec Pharm. 2016 Feb;22(2):114-20. doi: 10.18553/jmcp.2016.14251. Epub 2015 Dec 14.

17.
18.

Pharmaceutical technology assessment: perspectives from payers.

Leung MY, Halpern MT, West ND.

J Manag Care Pharm. 2012 Apr;18(3):256-64.

19.

Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.

Penm J, Chaar B, Moles R.

Res Social Adm Pharm. 2012 Jul-Aug;8(4):298-308. doi: 10.1016/j.sapharm.2011.07.003. Epub 2011 Dec 9.

PMID:
22169173
20.

Best practices in specialty pharmacy management.

Patterson CJ.

J Manag Care Pharm. 2013 Jan-Feb;19(1):42-8.

Supplemental Content

Support Center